Tobias Norstrom
Overview
Explore the profile of Tobias Norstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
170
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lannergard J, Cao S, Norstrom T, Delgado A, Gustafson J, Hughes D
PLoS One
. 2011 Dec;
6(11):e28366.
PMID: 22140579
FusE mutants are fusidic acid-resistant small colony variants (SCVs) of Staphylococcus aureus that can be selected with aminoglycosides. All FusE SCVs have mutations in rplF, encoding ribosomal protein L6. However,...
2.
Lannergard J, Norstrom T, Hughes D
Antimicrob Agents Chemother
. 2009 Mar;
53(5):2059-65.
PMID: 19289529
Resistance to fusidic acid in Staphylococcus aureus is caused by mutation of the elongation factor G (EF-G) drug target (FusA class) or by expression of a protein that protects the...
3.
Norstrom T, Lannergard J, Hughes D
Antimicrob Agents Chemother
. 2007 Oct;
51(12):4438-46.
PMID: 17923494
Small-colony variants (SCVs) of Staphylococcus aureus are a slow-growing subpopulation whose phenotypes can include resistance to aminoglycosides, defects in electron transport, and enhanced persistence in mammalian cells. Here we show...
4.
Kugelberg E, Norstrom T, Petersen T, Duvold T, Andersson D, Hughes D
Antimicrob Agents Chemother
. 2005 Jul;
49(8):3435-41.
PMID: 16048958
A new animal model for the purpose of studying superficial infections is presented. In this model an infection is established by disruption of the skin barrier by partial removal of...